Recombinant Murine Interleukin 4 Protein Therapy for Psoriasis in a Transgenic VEGF Mouse Model

Publisher： Karger

E-ISSN： 1421-9832|219|3|232-238

ISSN： 1018-8665

Source： Dermatology, Vol.219, Iss.3, 2009-08, pp. : 232-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin 4 or Cytokine Antagonists? Time to Change the Search for Novel Psoriasis Therapies

By  

Dermatology, Vol. 221, Iss. 1, 2010-06 ,pp. : 27-29

Karger

Access to resources Recommend Favorite

Interleukin 12 and Psoriasis

By  

Dermatology, Vol. 199, Iss. 2, 1999-10 ,pp. : 101-101

Karger

Access to resources Recommend Favorite

The Effect of Acitretin Treatment on Insulin Resistance, Retinol-Binding Protein-4, Leptin, and Adiponectin in Psoriasis Vulgaris: A Noncontrolled Study

By  

Dermatology, Vol. 227, Iss. 2, 2013-09 ,pp. : 103-108

Karger

Access to resources Recommend Favorite

Rapid Downregulation of Innate Immune Cells, Interleukin-12 and Interleukin-23 in Generalized Pustular Psoriasis with Infliximab in Combination with Acitretin

By  

Dermatology, Vol. 225, Iss. 4, 2013-01 ,pp. : 338-343

Karger

Access to resources Recommend Favorite

New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions

By  

Dermatology, Vol. 233, Iss. 1, 2017-05 ,pp. : 37-46

Karger

Access to resources Recommend Favorite